Academy Home / Webinars / Purrfect Microbiomes: Decoding the Feline Gut
Academy Home / Webinars / Purrfect Microbiomes: Decoding the Feline Gut
Join AnimalBiome’s experts, Dr. Connie Rojas and Dr. Holly Ganz, for an in-depth webinar on the feline gut microbiome. Using full-length 16S rRNA gene sequencing, we’ll define the core microbiome of 104 healthy cats and explore how factors like age, diet, and environment influence gut health. Gain insights into key bacterial species, microbiome diversity, and the impact of different diets on feline well-being. Don’t miss this opportunity to deepen your understanding of feline microbiome science!.
Test your knowledge and claim your certificate by completing the short quiz.
This clinical trial evaluated the impact of fecal microbiota transplantation (FMT) on dogs with tylosin-responsive enteropathy (TRE), focusing on clinical symptoms, fecal consistency, and microbiome composition. The trial had four phases, including screening, re-introduction of tylosin, treatment with FMT or placebo, and a follow-up. Both FMT and placebo groups showed improved microbiome diversity after treatment. On average, 30.4% of donor bacterial strains engrafted in FMT recipients.
Fecal microbiota transplantation (FMT) is a promising new therapy for dogs with gastrointestinal issues. However, safety concerns and a lack of understanding of its mechanisms limit its wider use. This paper reviews the current applications and efficacy of canine FMT, explores its potential mechanisms, and discusses future directions for research, including donor selection, recipient preparation, administration routes, stool storage, and potential applications beyond gastrointestinal disorders.
This study explores the effects of fecal microbiota transplants (FMTs) in domestic cats with chronic digestive issues using oral capsules containing lyophilized stool. Changes in bacterial composition, including shifts in Clostridium, Collinsella, and Escherichia, were observed post-FMT, as well as donors sharing 13% of their bacterial variants with recipientsThe study suggests that FMT outcomes are influenced by the recipient's symptoms, diet, and donor microbiome.
The Companion Animal FMT Consortium aims to increase accessibility of FMT as a microbial-directed therapeutic for dogs and cats by simplifying and demystifying the process of performing FMT in clinical practice. These FMT clinical guidelines are intended for veterinarians in a variety of clinical practice types and can be modified and adapted as needed to align with financial and technical resources available to individual practitioners.
Help us improve future webinars by taking a quick survey about your experience today.
December 2024 - RACE-Approved
Join us for an insightful webinar regarding FMT with our veterinary panelists and hosted by Dr. Tonya Cooksey, DVM, AnimalBiome’s Director of Veterinary Relations. The webinar will discuss the history of FMT, its current uses in veterinary practice, and its potential for treating various conditions in companion animals.
August 2024 - RACE-Approved
Join this webinar to explore groundbreaking research on the canine fecal microbiome, its core bacterial species, and the impact of different dietary regimens on gut health.